Aliev B M, Chuprik-Malinovskaia T P, Aleknavichius E E
Med Radiol (Mosk). 1988 Jun;33(6):37-41.
The authors presented comparative analysis of the results of hyperfractionated gamma-irradiation of 75 patients with locally advanced head and neck tumors (stages II-IV) in various types of daily dose fractionation. 33 patients of the 1st group received radiotherapy at a dose of 1.2 Gy twice a day at a 6h-interval up to a total dose of 70-75 Gy, 23 patients of the 2nd group were irradiated at a dose of 1 Gy 3 times a day at a 3h-interval up to a total dose of 60-65 Gy, 19 patients of the 3rd group were irradiated at a dose of 1 Gy 5 times a day up to a total dose of 60 Gy. The authors have shown the prospects of hyperfractionated irradiation with two- and threefold daily dose fractionation in which complete tumor resorption was 94-95%, the 2-year survival was 60.6 +/- 7 and 75%, respectively without signs of late complications.
作者对75例局部晚期头颈部肿瘤(II-IV期)患者在不同类型每日剂量分割情况下进行超分割伽马射线照射的结果进行了比较分析。第一组33例患者每天两次接受1.2 Gy的放疗,间隔6小时,总剂量达70-75 Gy;第二组23例患者每天三次接受1 Gy的照射,间隔3小时,总剂量达60-65 Gy;第三组19例患者每天五次接受1 Gy的照射,总剂量达60 Gy。作者展示了每日两次和三次剂量分割的超分割照射的前景,其中肿瘤完全吸收分别为94%-95%,2年生存率分别为60.6±7%和75%,且无晚期并发症迹象。